Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PerciaVista is an early-stage medical technology company dedicated to improving the management of glaucoma through continuous intraocular pressure (IOP) monitoring. The company is developing a wireless, battery-less implantable sensor that provides real-time, long-term data on IOP fluctuations, which are often missed by traditional clinical tonometry. By capturing these critical pressure changes, PerciaVista's platform enables clinicians to make more informed decisions regarding medication, laser therapy, or surgical intervention. The technology is designed for seamless integration into existing ophthalmic procedures, aiming to provide a personalized approach to preventing irreversible vision loss.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PerciaVista.